A Form 4 filed on October 28, 2026, discloses that Kyle Malady, EVP and Group CEO-VZ Business at Verizon Communications Inc., sold 1,100 shares of common stock on October 27, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Kyle Malady, identified in the filing as EVP and Group CEO-VZ Business at Verizon Communications Inc. (NYSE:VZ).
  • Transaction: 1,100 shares of common stock disposed of (transaction code S) on October 27, 2026, at a price of $43 per share.
  • 10b5-1 plan: The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Malady on May 18, 2026.
  • Direct holdings after transaction: 98,866 shares of common stock held directly following the reported transaction.
  • Indirect holdings: 20,219 shares held indirectly through a 401(k) plan, as reported in the filing.
  • Signed by: Evgeniya Berezkina, listed as attorney-in-fact for Kyle Malady, on October 28, 2026.

Malady's October 2026 Verizon Share Disposition: Filing Details

According to the Form 4, Kyle Malady, who serves as EVP and Group CEO-VZ Business at Verizon Communications Inc., disposed of 1,100 shares of Verizon common stock on October 27, 2026, at a price of $43 per share. The filing indicates the transaction code was "S" and the shares were classified as disposed of (D). The filing also notes that a check box was marked to indicate the transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

The filing's explanation of responses states that "this transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2026." Following the sale, Malady's directly held position in Verizon common stock stands at 98,866 shares, according to the filing. In addition, the filing reports 20,219 shares held indirectly by Malady through a 401(k) plan. No derivative securities transactions were reported in Table II of the filing.

The Form 4 was signed by Evgeniya Berezkina as attorney-in-fact for Kyle Malady and was filed on October 28, 2026, with the date of earliest transaction listed as October 27, 2026. The filing was submitted as an individual filing by one reporting person.

What Was Disclosed

The filing discloses a single open-market sale of 1,100 Verizon common shares by EVP Kyle Malady on October 27, 2026, at $43 per share, under a 10b5-1 plan adopted May 18, 2026, leaving Malady with 98,866 directly held shares and 20,219 shares held indirectly via a 401(k).